← Leaderboards
Wolfgang Sadee
University Of California San Francisco
$12,715,968
Attributed
$13,466,693
Total exposure
8
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2005–20$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$13,466,693 · 8
By mechanism
U01$8,603,459 · 1
R01$2,884,153 · 3
R44$1,501,451 · 1
R21$467,750 · 2
P41$9,880 · 1
Top collaborators
- Rick Hawkins3 shared
Most similar at University Of California San Francisco
Same institution · by research overlap
- Steven L Batki$8,802,367
- James L. Sorensen$27,892,556
- Diane L Barber$14,515,797
- Robert Adron Harris$33,954,196
Others in their field
Top investigators on “Affect”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$287,585,588
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$209,385,844
- David Heimbrook · Leidos Biomedical Research, Inc.$168,138,264
- Daniel R Kuritzkes · Brigham And Women'S Hospital$151,687,019
Research focus
AffectBrainGenotypeAllelesGene ExpressionGenesPromotor (Genetics)PlayMrna ExpressionMolecularSurveysGene TargetingVariantGeneticPathway InteractionsPatternInsightNovel StrategiesProtein ExpressionDrd2 GeneEnzymesLeadEpigenetic ProcessComplex
Grant awards (28)
Development of a Neonatal Abstinence Syndrome Therapy$128,250
R44 · FY2020 · DA
Development of a Neonatal Abstinence Syndrome Therapy$1,148,201
R44 · FY2019 · DA
Development of a Neonatal Abstinence Syndrome Therapy$225,000
R44 · FY2018 · DA
Expression Genetics in Drug Therapy$1,587,669
U01 · FY2014 · GM · contact PI
Expression Genetics in Drug Therapy$1,531,745
U01 · FY2013 · GM · contact PI
Expression Genetics in Drug Therapy$1,586,888
U01 · FY2012 · GM · contact PI
Expression Genetics in Drug Therapy$1,570,156
U01 · FY2011 · GM · contact PI
Expression Genetics in Drug Therapy$2,327,001
U01 · FY2010 · GM · contact PI
Genetic and Epigenetic Regulation of Addiction Genes$330,516
R01 · FY2010 · DA · contact PI
Genetic and Epigenetic Regulation of Addiction Genes$333,855
R01 · FY2009 · DA · contact PI
Genetic and Epigenetic Regulation of Addiction Genes$341,540
R01 · FY2008 · DA · contact PI
Serotonin-related genes in human brain$168,750
R21 · FY2008 · MH · contact PI
Genetic and Epigenetic Regulation of Addiction Genes$340,668
R01 · FY2007 · DA · contact PI
Genetic and Epigenetic Regulation of Addiction Genes$7,640
R01 · FY2007 · DA · contact PI
Genetic and Epigenetic Regulation of Addiction Genes$366,130
R01 · FY2006 · DA · contact PI
Polymorphisms in Regulatory Regions of Addiction Genes$149,500
R21 · FY2005 · DA
Polymorphisms in Regulatory Regions of Addiction Genes$149,500
R21 · FY2004 · DA
OPIOID RECEPTOR REGULATION$194,777
R01 · FY2003 · DA
OPIOID RECEPTOR REGULATION$21,594
R01 · FY2003 · DA
OPIOID RECEPTOR REGULATION$189,007
R01 · FY2002 · DA
BIOTINYLATED ENDORPHIN AS PROBE FOR OPIATE RECEPTOR$0
P41 · FY2002 · RR
MUTATIONS OF MUSCARINIC CHOLINERGIC RECEPTOR GENES$187,125
R01 · FY2001 · GM
OPIOID RECEPTOR REGULATION$183,009
R01 · FY2001 · DA
MUTATIONS OF MUSCARINIC CHOLINERGIC RECEPTOR GENES$17,633
R01 · FY2001 · GM
BIOTINYLATED ENDORPHIN AS PROBE FOR OPIATE RECEPTOR$0
P41 · FY2001 · RR
MUTATIONS OF MUSCARINIC CHOLINERGIC RECEPTOR GENES$192,933
R01 · FY2000 · GM
OPIOID RECEPTOR REGULATION$177,726
R01 · FY2000 · DA
BIOTINYLATED ENDORPHIN AS PROBE FOR OPIATE RECEPTOR$9,880
P41 · FY2000 · RR